Importantly, these phenotypic changes are visible in the pre-invasive state, where DCIS lesions adjacent to invasive disease show significantly lower expression of thioredoxin interacting protein but significantly higher expression of legumain, compared to pure DCIS lesions (Table 5). The gene discussed is TXN; the disease is ductal breast carcinoma in situ.